Home Capital Group Inc.: Why it’s Important to Listen to the Short-Sellers

Home Capital Group Inc. (TSX:HCG) has been hit hard by short-sellers, and it may be time to take some of the assertions seriously.

| More on:
The Motley Fool

Home Capital Group Inc. (TSX:HCG) continues its decline following the abrupt dismissal of CEO Martin Reid, as market participants consider the allegations brought forward by the Ontario Securities Commission (OSC) and investors who have filed a class-action lawsuit against the Canadian lender, alleging large-scale fraud related to the disclosures made by Home Capital over a two-year period.

Last week, in a scathing interview with BNN, a popular short-seller outlined many of the risks associated with the Home Capital management team and business model; it’s consistent with my bearish view on this company and another, Equitable Group Inc.

Fool contributor Ryan Goldsman, however, suggests that Home Capital “could become the next 150% return over the next five years” and that “the potential for large returns are potentially imminent.” These assertions are made using very basic math, calculating backwards what the ratios would be should the stock price appreciate 150% over five years — an increase to 10-20% above record levels. The asserted drivers of this massive increase in the company’s stock price are two-fold: (1) interest rates increase, and (2) consumers continue to shop around for prices on loans.

This logic ignores the massive legal and operational problems Home Capital has and are dangerous assumptions for two reasons.

First, interest rate increases and consumer diligence are two variables affecting all lending companies. Other competitors can simply lower their rates or cut margins to become more competitive, and if Home Capital’s lending policies are such that it will undercut competitors, the company is forfeiting margins, taking on excess risk, or both.

Second, even if Home Capital’s stock price gets a minor bump from interest rates increasing or increased demand for the company’s loans, these advances will likely be more than offset by the deteriorating fundamentals of the business.

I’ll be the first one to say that nothing is impossible. Perhaps Home Capital is not as poorly run as the short-sellers suggest. Perhaps the ratios are out of wack, and the company really is cheap.

However, as I’ve said before, just because a stock is cheap doesn’t make it a value play.

Market forces are at work for Home Capital, and the market has indicated that the problems underneath the surface may be more worrisome than the company is willing to admit. The snap dismissal of CEO Martin Reid and the subsequent interim CEO replacement widely perceived to be under qualified for the job are astounding developments, and relatively unheard of in corporate Canada.

Short-sellers play an important role in the market pricing mechanism for stocks, signalling to other investors that an investment is less valuable than the market indicates. Short-sellers from south of the border (and I don’t know why where someone is from matters), including infamous short-seller Marc Cohodes, have indicated that Home Capital is a company with much bigger problems that are being covered up.

Cohodes has noted in the past that the company’s fundamentals, its massive exposure to oil-laden Alberta, the fact that the company has a very small provision for credit losses, and Home Capital’s inept management team (which he appears to be right about) are just some of the reasons he has shorted this company since the fall of 2014.

It should be noted that Cohodes announced short positions against five Canadian companies (in addition to his U.S. short plays). Among the companies he shorted were Concordia International Corp., which is down 98.3% from its peak, Valeant Pharmaceuticals Intl Inc., which is down 96.2% from its peak, Intertain Group, which is down 55.9% from its peak, Home Capital, which is down 55.6% from its peak, and Equitable Group Inc., which is currently trading at slightly below its peak (and a company I believe to be overvalued as well). That’s not a bad track record.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of HOME CAPITAL GROUP INC. and Valeant Pharmaceuticals.

More on Bank Stocks

Confused person shrugging
Bank Stocks

Royal Bank vs. National Bank: Where Should You Park Your Investment Capital?

If we go by growth alone, it's easy to identify the top contender in the Canadian banking sector, but a…

Read more »

calculate and analyze stock
Bank Stocks

Is Canadian Imperial Bank of Commerce a Buy for its 4% Dividend Yield?

Besides its 4% annualized dividend yield, these top reasons make Canadian Imperial Bank stock really attractive for long-term investors right…

Read more »

ways to boost income
Bank Stocks

2 Undervalued Canadian Bank Stocks to Buy Now

These Big Six Banks offer growth potential and reliable dividend payments.

Read more »

Man holds Canadian dollars in differing amounts
Bank Stocks

Got $1,000? BNS Stock Can Turn it Into a Passive-Income Stream

Down more than 20% from all-time highs, Bank of Nova Scotia currently offers a tasty dividend yield of over 6%…

Read more »

dividend growth for passive income
Top TSX Stocks

1 Magnificent Canadian Stock Down 9 Percent to Buy and Hold Forever

There are some really great stocks on the market for any portfolio, but this one magnificent Canadian stock screams buy.

Read more »

Paper Canadian currency of various denominations
Bank Stocks

Is BNS Stock a Buy, Sell, or Hold for 2025?

Bank of Nova Scotia (TSX:BNS) is one of Canada's big bank stocks, but should you buy, sell or hold BNS…

Read more »

A worker uses a double monitor computer screen in an office.
Bank Stocks

Is BNS Stock a Buy for its Dividend Yield?

Bank of Nova Scotia is up nearly 30% in the past year. Are more gains on the way?

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Bank Stocks

Best Stock to Buy Right Now: TD Bank or Manulife Financial?

Manulife continues to see momentum in its business and stock price, while TD Bank stock remains down and out.

Read more »